Vasopressin
Vasopressin is a hormone and medication belonging to the antidiuretic hormone (ADH) class. It is primarily used to treat diabetes insipidus, certain cases of low blood pressure (hypotension), and vasodilatory shock. It works by activating V1 and V2 receptors, causing blood vessels to constrict and increasing water reabsorption in the kidneys. This helps maintain blood pressure, regulate body water balance, and reduce excessive urine production. Vasopressin is commonly administered through intravenous injection or infusion, depending on the medical condition. Common side effects include headache, abdominal cramps, nausea, and sweating. Serious adverse effects may include reduced blood flow to certain organs, low sodium levels, and abnormal heart rhythms. It should be administered under medical supervision with careful monitoring of blood pressure and electrolyte levels.
Vasopressin was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:
is okay
The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.
Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Vasopressin, subject to confirmation of its current regulatory status and eligibility for import into India.
The export of Vasopressin from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.
Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Vasopressin, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.
If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.
